MHP SE/ US55302T2042 /
2022-05-26 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
4.3300USD | - | 70 Turnover: - |
-Bid Size: - | -Ask Size: - | 4.3300 | 4.3300 |
GlobeNewswire
05-10
PharmaTher Announces Assigned FDA Approval Goal Date of its Priority Original Abbreviated New Drug A...
GlobeNewswire
05-08
PolyPid Provides Corporate Update and Reports First Quarter 2024 Financial Results
GlobeNewswire
04-30
PolyPid Announces Enrollment of 200th Patient in Ongoing SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀...
GlobeNewswire
04-18
PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine
GlobeNewswire
04-16
PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine
GlobeNewswire
02-12
PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine
GlobeNewswire
02-12
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial
GlobeNewswire
01-31
PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on ...
GlobeNewswire
2023-11-08
PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results
GlobeNewswire
2023-11-07
PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors
GlobeNewswire
2023-10-04
PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PL...
GlobeNewswire
2023-09-27
PharmaTher Announces FDA Acceptance, As a Priority Original Abbreviated New Drug Application, for KE...
GlobeNewswire
2023-09-22
Giga Metals Announces Positive Pre-Feasibility Study for the Turnagain Nickel-Cobalt Deposit
GlobeNewswire
2023-09-22
Giga Metals Announces Positive Pre-Feasibility Study for the Turnagain Nickel-Cobalt Deposit
GlobeNewswire
2023-09-22
PolyPid to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
GlobeNewswire
2023-09-21
PolyPid Announces Successful Commercial Good Manufacturing Practice (GMP) Audit by Israeli Ministry ...
GlobeNewswire
2023-09-19
PolyPid Announces Successful Completion of Manufacturing Process Validation for D-PLEX₁₀₀
GlobeNewswire
2023-09-06
PharmaTher Submits Priority Original Abbreviated New Drug Application for KETARX™ (Ketamine) to the ...